Journal article icon

Journal article

The relationship between glutamate, dopamine, and cortical gray matter: A simultaneous PET-MR study

Abstract:
Prefrontal cortex has been shown to regulate striatal dopaminergic function via glutamatergic mechanisms in preclinical studies. Concurrent disruption of these systems is also often seen in neuropsychiatric disease. The simultaneous measurement of striatal dopamine signaling, cortical gray matter, and glutamate levels is therefore of major interest, but has not been previously reported. In the current study, twenty-eight healthy subjects underwent 2 simultaneous [11C]-( + )-PHNO PET-MRI scans, once after placebo and once after amphetamine in a double-blind randomized cross-over design, to measure striatal dopamine release, striatal dopamine receptor (D2/3R) availability, anterior cingulate glutamate+glutamine (Glx) levels, and cortical gray matter volumes at the same time. Voxel-based morphometry was used to investigate associations between neurochemical measures and gray matter volumes. Whole striatum D2/3R availability was positively associated with prefrontal cortex gray matter volume (pFWE corrected = 0.048). This relationship was mainly driven by associative receptor availability (pFWE corrected = 0.023). In addition, an interaction effect was observed between sensorimotor striatum D2/3R availability and anterior cingulate Glx, such that in individuals with greater anterior cingulate Glx concentrations, D2/3R availability was negatively associated with right frontal cortex gray matter volumes, while a positive D2/3R-gray matter association was observed in individuals with lower anterior cingulate Glx levels (pFWE corrected = 0.047). These results are consistent with the hypothesis that the prefrontal cortex is involved in regulation of striatal dopamine function. Furthermore, the observed associations raise the possibility that this regulation may be modulated by anterior cingulate glutamate concentrations
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Files:
Publisher copy:
10.1038/s41380-022-01596-6
Publication website:
https://discovery.ucl.ac.uk/10148720/1/Nour_s41380-022-01596-6.pdf

Authors

More by this author
Role:
Author
ORCID:
0000-0002-3993-3954
More by this author
Role:
Author
ORCID:
0000-0002-7835-2992
More by this author
Role:
Author
ORCID:
0000-0003-3562-0683
More by this author
Role:
Author
ORCID:
0000-0003-3634-7375
More by this author
Institution:
University of Oxford
Role:
Author
ORCID:
0000-0003-0858-6184


More from this funder
Funder identifier:
10.13039/100004440
Grant:
215747/Z/19/Z
More from this funder
Funder identifier:
10.13039/100012176
Grant:
666
More from this funder
Funder identifier:
10.13039/501100000265
Grant:
MC_U120097115


Publisher:
Springer Nature [academic journals on nature.com]
Journal:
Molecular Psychiatry More from this journal
Volume:
27
Issue:
8
Pages:
3493-3500
Publication date:
2022-05-11
DOI:
EISSN:
1476-5578
ISSN:
1359-4184


Language:
English
Keywords:
Pubs id:
1274449
Local pid:
pubs:1274449
Source identifiers:
W4280517603
Deposit date:
2026-04-28
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP